Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV002247282 | SCV002518424 | uncertain significance | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002512947 | SCV003525372 | uncertain significance | not provided | 2022-07-10 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects P2RY12 function (PMID: 12578987, 29117459). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 9083). This missense change has been observed in individual(s) with bleeding disorder (PMID: 12578987, 32100410). This variant is present in population databases (rs121917886, gnomAD 0.006%). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 265 of the P2RY12 protein (p.Arg265Trp). |
OMIM | RCV000009651 | SCV000029869 | pathogenic | Platelet-type bleeding disorder 8 | 2017-06-14 | no assertion criteria provided | literature only |